Revlimid — Carefirst Caremark
17 indications indexed for this drug.
- B Cell LymphomasView coverage criteria
- B Cell Lymphomas Hiv Related B Cell Lymphomas Monomorphic PoView coverage criteria
- Chronic Lymphocytic Leukemia Cll Small Lymphocytic LymphomaView coverage criteria
- Classic Hodgkin LymphomaView coverage criteria
- Histiocytic NeoplasmsView coverage criteria
- Histiocytic Neoplasms Langerhans Cell Histiocytosis Rosai DoView coverage criteria
- Kaposi SarcomaView coverage criteria
- Multicentric Castleman DiseaseView coverage criteria
- Multiple MyelomaView coverage criteria
- Myelodysplastic Myeloproliferative NeoplasmsView coverage criteria
- Myelodysplastic SyndromeView coverage criteria
- Myelofibrosis Associated AnemiaView coverage criteria
- Poems SyndromeView coverage criteria
- Primary Central Nervous System Cns LymphomaView coverage criteria
- Smoldering MyelomaView coverage criteria
- Systemic Light Chain AmyloidosisView coverage criteria
- T Cell Lymphomas Peripheral T Cell Lymphomas Not Otherwise SView coverage criteria